Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Athersys: Grossly Undervalued Given Its Potential
Seeking Alpha
Sunday, May 1, 2011 - 4:20pm
tags:
Athersys, allogeneic cells, stem cells
The Next Big Thing In Biotech: Dendreon, Avanir (video)
The Street
Sunday, May 1, 2011 - 4:19pm
tags:
Dendreon, Avanir
Glaxo's growth is not an accident: Andrew Witty, global CEO
Economic Times, India
Saturday, April 30, 2011 - 11:36am
tags:
GSK, Andrew Witty
Emerging botulinum toxins enter the cosmetic market
Modern Medicine
Saturday, April 30, 2011 - 11:33am
tags:
botulinum toxin A, Botoxm, Dysport, Xeomin, Merz, PurTox, Mentor, incobotulinumtoxinA
ICON and ACRONET Sign Alliance Agreement For Clinical Development
Bioresearch Online
Saturday, April 30, 2011 - 11:31am
tags:
ICON, ACRONET, clinical development services
Drug Companies Stocks Underperfoming: JNJ, NVS, PFE
Trader's Huddle
Saturday, April 30, 2011 - 11:27am
tags:
JNJ, Novartis, Pfizer
Sellers in Control - Endo Pharmaceuticals
Trader's Huddle
Saturday, April 30, 2011 - 11:26am
tags:
Endo
Merry First-Quarter For Merck As Earnings Triple
Forbes
Saturday, April 30, 2011 - 11:26am
tags:
Merck, earnings
Earnings Preview: Pfizer reports on first quarter
Yahoo/AP
Saturday, April 30, 2011 - 11:24am
tags:
Pfizer, earnings
Nice Efficacy, Pfizer, But...
Motley Fool
Saturday, April 30, 2011 - 10:09am
tags:
Pfizer, tofacitinib, rheumatoid arthritis
Abbott Receives U.S. FDA Approval for AndroGel® 1.62% to Treat Men with Low Testosterone
Yahoo/PR NewsWire
Saturday, April 30, 2011 - 10:08am
tags:
Androgel, testosterone, Abbott Laboratories
Genentech, Once Known For Innovation, Is Pursuing A Nexium Strategy With Lucentis
Forbes
Saturday, April 30, 2011 - 10:07am
tags:
Genentech, Lucentis, macular degeneration
Johnson & Johnson’s Centocor Withdraws Trabectedin Application
Bloomberg
Saturday, April 30, 2011 - 10:04am
tags:
JNJ, Janssen Biotech, Trabectedin, ovarian cancer
Fitch considers J&J downgrade on buyout
Yahoo/AP
Saturday, April 30, 2011 - 10:03am
tags:
JNJ
Pfizer!: What Went Wrong This Week and Why? (video)
The Street
Saturday, April 30, 2011 - 10:02am
tags:
Pfizer
Investing in High Dividend Healthcare Stocks
Seeking Alpha
Saturday, April 30, 2011 - 10:02am
tags:
Merck & Co.'s CEO Discusses Q1 2011 Results - Earnings Call Transcript
Seeking Alpha
Saturday, April 30, 2011 - 10:00am
tags:
Merck, earnings
Why Is Abbott’s TriLipix Defying Gravity?
Forbes
Saturday, April 30, 2011 - 10:00am
tags:
Abbott Laboratories, TriLipix, TriCor, fibrates
Loss at HGSI Wider than Expected
Yahoo/Zacks
Saturday, April 30, 2011 - 9:57am
tags:
Human Genome Sciences, earnings
Medivation Shares Popped: What You Need to Know
Motley Fool
Saturday, April 30, 2011 - 9:56am
tags:
Medivation, MDV3100, prostate cancer, Alzheimer's disease, dimebon

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.